文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

消除麻疹进展——世界卫生组织东地中海区域,2019-2022年

Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-02-22

2015年世界卫生组织东地中海区域全部22个国家和地区承诺2020年消除麻疹,但多数国家仍未实现。本报告描述2019-2022年进展:含麻疹成分疫苗第一剂和第二剂估算区域覆盖率分别为82%-83%和76%-78%;报告确诊麻疹发病率从2019年29.8例/百万降至2020年7.4例/百万,后因COVID-19大流行挑战增至2022年50.0例/百万;11个(50%)国家监测指标恶化;4个国家被核实达到消除。

要点

  • 2019-2022年含麻疹成分疫苗第一剂和第二剂估算区域覆盖率分别为82%-83%和76%-78%。
  • 报告确诊麻疹发病率从2019年29.8例/百万降至2020年7.4例/百万,后增至2022年50.0例/百万。
  • 22个东地中海区域国家中11个(50%)监测指标恶化,4个国家被核实达到消除。

核心结论

  • 东地中海区域多数国家尚未消除麻疹,2022年部分国家报告免疫空白和麻疹发病率上升。
  • 要实现区域消除麻疹,国家免疫规划需继续从COVID-19大流行中恢复、提高总体疫苗接种覆盖率以填补免疫空白并维持高质量疾病监测。

研究设计与样本

  • 本报告更新此前报告,描述世界卫生组织东地中海区域22个国家和地区2019-2022年消除麻疹进展。

主要发现

  • 2019-2022年含麻疹成分疫苗第一剂和第二剂估算区域覆盖率分别为82%-83%和76%-78%。
  • 报告确诊麻疹发病率从2019年29.8例/百万降至2020年7.4例/百万,后增至2022年50.0例/百万。
  • 22个东地中海区域国家中11个(50%)监测指标恶化。
  • 2019-2022年区域内4个国家被核实达到消除麻疹。

临床怎么用

  • 国家免疫规划需继续从COVID-19大流行中恢复,提高总体疫苗接种覆盖率以填补免疫空白,并维持高质量疾病监测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2015, all 22 World Health Organization Eastern Mediterranean Region (EMR) countries and areas (countries) pledged to achieve measles elimination by 2020. Despite success in several countries, most countries in the region still have not eliminated measles. This report updates a previous report and describes progress toward measles elimination in EMR during 2019-2022. During that period, estimated regional coverage with the first and second doses of a measles-containing vaccine (MCV) was 82%-83% and 76%-78%, respectively. During 2019-2022, approximately 160 million children were vaccinated during national or subnational supplementary immunization activities. Reported confirmed regional measles incidence decreased from 29.8 cases per 1 million population in 2019 to 7.4 in 2020, but then increased 68%, to 50.0 in 2022 because of challenges providing immunization services and conducting surveillance during the COVID-19 pandemic. Surveillance indicators deteriorated in 11 (50%) of the 22 EMR countries. During 2019-2022, four countries in the region were verified as having achieved measles elimination, but other countries reported immunity gaps and increased measles incidence in 2022. To achieve measles elimination in EMR, national immunization programs, especially in those countries with high measles incidence, will need to continue to recover from the COVID-19 pandemic, increase overall vaccination coverage to close immunity gaps, and maintain high-quality disease surveillance.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Musa N, Ghoniem A, Hsu CH, et al. Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38386606. doi:10.15585/mmwr.mm7307a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。